Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,816 | 1,014 | 99.6% |
| Education | $76.37 | 10 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,689 | 121 | $0 (2024) |
| Lilly USA, LLC | $2,647 | 172 | $0 (2024) |
| Dexcom, Inc. | $2,441 | 122 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,593 | 74 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,202 | 50 | $0 (2023) |
| ABBVIE INC. | $981.95 | 49 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $876.91 | 45 | $0 (2023) |
| Esperion Therapeutics, Inc. | $715.02 | 28 | $0 (2024) |
| Amgen Inc. | $642.34 | 19 | $0 (2024) |
| Abbott Laboratories | $549.87 | 30 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,995 | 79 | BETA BIONICS, INC. ($383.68) |
| 2023 | $1,908 | 115 | Lilly USA, LLC ($383.25) |
| 2022 | $2,515 | 146 | Dexcom, Inc. ($513.29) |
| 2021 | $3,123 | 171 | DEXCOM, INC. ($544.62) |
| 2020 | $2,103 | 108 | Novo Nordisk Inc ($288.80) |
| 2019 | $3,782 | 140 | Novo Nordisk Inc ($509.18) |
| 2018 | $2,304 | 121 | Novo Nordisk Inc ($458.32) |
| 2017 | $3,163 | 144 | Boehringer Ingelheim Pharmaceuticals, Inc. ($351.16) |
All Payment Transactions
1,024 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $15.94 | General |
| 12/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Insomnia | ||||||
| 12/05/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $15.51 | General |
| Category: Insulin Pump | ||||||
| 11/21/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $122.32 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/20/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $19.71 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $28.75 | General |
| 11/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Obesity | ||||||
| 11/05/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Durable Pump | ||||||
| 10/22/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $18.51 | General |
| 10/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Endocrinology | ||||||
| 09/25/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $111.32 | General |
| Category: Insomnia | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: Endocrinology | ||||||
| 08/29/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/28/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $47.04 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 409 | 592 | $81,115 | $30,963 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 209 | 318 | $57,240 | $23,520 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $13,050 | $4,658 | 35.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 23 | 23 | $5,750 | $1,363 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $1,690 | $741.07 | 43.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 106 | 179 | $2,685 | $567.61 | 21.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 14 | $700.00 | $113.54 | 16.2% |
About Dr. Ghyass Rizk, MD
Dr. Ghyass Rizk, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144267360.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ghyass Rizk, MD has received a total of $20,892 in payments from pharmaceutical and medical device companies, with $1,995 received in 2024. These payments were reported across 1,024 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($20,816).
As a Medicare-enrolled provider, Rizk has provided services to 409 Medicare beneficiaries, totaling 592 services with total Medicare billing of $30,963. Data is available for 1 year (2023–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Lafayette, LA
- Active Since 05/31/2006
- Last Updated 10/17/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144267360
Products in Payments
- FARXIGA (Drug) $1,569
- JARDIANCE (Drug) $1,456
- Ozempic (Drug) $1,250
- Dexcom G6 Transmitter (Medical Supply) $1,203
- TRULICITY (Drug) $790.60
- DEXCOM G6 TRANSMITTER (Device) $544.62
- INVOKANA (Drug) $520.74
- Synthroid (Drug) $506.68
- Vascepa (Drug) $485.90
- NEXLETOL (Drug) $477.74
- CYCLOSET (Drug) $477.60
- DEXCOM CGM (Device) $467.67
- HUMULIN (Drug) $414.96
- BAQSIMI (Drug) $393.68
- iLet Bionic Pancreas (Device) $383.68
- MOUNJARO (Drug) $345.96
- QUVIVIQ (Drug) $337.14
- EVENITY (Biological) $332.69
- TRADJENTA (Drug) $302.24
- Korlym (Drug) $293.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Lafayette
Dr. Justin Fontenot, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $502,420
Dona Gray, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $206,781
Dr. Bennett Baquet, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $37,139
Daniel Stout, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $24,772
Shannon Oates, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $97.19
Dr. Laura Wolsko, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $23.31